19 filings
8-K
PRNB
Principia Biopharma Inc.
9 Dec 19
Principia Presents Consistent Positive Data of PRN1008
6:09am
8-K
PRNB
Principia Biopharma Inc.
5 Nov 19
Principia Biopharma Reports Third Quarter Financial Results
4:10pm
8-K
PRNB
Principia Biopharma Inc.
18 Oct 19
Entry into a Material Definitive Agreement
4:14pm
8-K
PRNB
Principia Biopharma Inc.
15 Oct 19
Principia Announces Positive Preliminary Data of PRN1008 for Immune Thrombocytopenia in Ongoing Phase 1/2 Trial
7:09am
8-K
PRNB
Principia Biopharma Inc.
10 Oct 19
Principia Announces Positive Preliminary Data of PRN1008 from its
7:00am
8-K
ofoy51bo
30 Aug 19
Departure of Directors or Certain Officers
4:10pm
8-K
d3hynnx
8 Aug 19
Principia Biopharma Reports Second Quarter Financial Results
4:11pm
8-K
nzt3zzl7yqvlwt01
14 Jun 19
Departure of Directors or Certain Officers
4:05pm
8-K
ocdt2e
15 May 19
Principia Biopharma Announces First Patient Dosed in Sanofi’s Phase 2b Trial of SAR442168 in Multiple Sclerosis, Triggering $30 Million Milestone
9:01am
8-K
cw209i eaxu
14 May 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:05pm
8-K
owcxo2311dhp arx
7 May 19
Principia Biopharma Reports First Quarter Financial Results
4:05pm
8-K
btm0mk80u8
22 Apr 19
Material Modifications to Rights of Security Holders
4:05pm
8-K
xsatqha1yxxj
26 Mar 19
Other Events
4:58pm
8-K
gcso 0899k
19 Mar 19
Principia Biopharma Reports Fourth Quarter and Full Year 2018 Financial Results
4:10pm
8-K
x8afdlm7pj9rd
13 Mar 19
Termination of a Material Definitive Agreement
1:19pm
8-K
nsmqgp7gd2b0no4
4 Mar 19
Principia Biopharma Presents Phase 1 Clinical Data from CNS Penetrating
2:25pm
8-K
rb56pai5u78ux ep5ksc
28 Feb 19
Other Events
3:26pm
8-K
0plezqqcvjx
19 Feb 19
Departure of Directors or Certain Officers
5:09pm
8-K
gp6ll3sw
4 Feb 19
Other Events
5:00pm
- Prev
- 1
- Next